+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer

Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer

World Journal of Gastroenterology 22(11): 3117-3126

Inflammatory bowel diseases are characterised by inflammation that compromises the integrity of the epithelial barrier. The intestinal epithelium is not only a static barrier but has evolved complex mechanisms to control and regulate bacterial interactions with the mucosal surface. Apical tight junction proteins are critical in the maintenance of epithelial barrier function and control of paracellular permeability. The characterisation of alterations in tight junction proteins as key players in epithelial barrier function in inflammatory bowel diseases is rapidly enhancing our understanding of critical mechanisms in disease pathogenesis as well as novel therapeutic opportunities. Here we give an overview of recent literature focusing on the role of tight junction proteins, in particular claudins, in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 059133227

Download citation: RISBibTeXText

PMID: 27003989

DOI: 10.3748/wjg.v22.i11.3117

Related references

Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology. Zeitschrift für Gastroenterologie 51(5): 450-457, 2014

Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey. Journal of Gastroenterology 47(12): 1308-1322, 2012

Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution. Medical Hypotheses 110: 31-37, 2018

Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis. Clinical and Translational Oncology 19(8): 1018-1027, 2017

Effects of Bacillus subtilis on Epithelial Tight Junctions of Mice with Inflammatory Bowel Disease. Journal of Interferon and Cytokine Research 36(2): 75-85, 2016

Alterations of hepatocyte tight junctions in a rat model of inflammatory bowel disease are prevented by polymyxin B. Hepatology 28(4 Part 2): 430A, 1998

Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases. Clinical Gastroenterology and Hepatology 12(8): 1342-8.E1, 2014

Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer. Therapeutic Advances in Gastroenterology 4(1): 49-62, 2011

Pathology and pathophysiology of inflammatory bowel diseases. Development of inflammatory bowel disease due to disruption of the intestinal immuno-regulatory mechanism. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 98(1): 12-17, 2009

Consensus of the Austrian working group for inflammatory bowel disease of the OEGGH concerning the diagnosis and therapy of inflammatory bowel diseases in the adolescence. Zeitschrift fuer Gastroenterologie 38(9): 791-794, 2000

Quality of life in patients with inflammatory bowel diseases: translation to Portuguese language and validation of the "Inflammatory Bowel Disease Questionnaire" (IBDQ). Arquivos de Gastroenterologia 41(2): 137-143, 2004

Origins and Directions of Inflammatory Bowel Disease, Early Studies of the Nonspecific Inflammatory Bowel Diseases. Gastroenterology 124(3): 861-862, 2003

Inflamed pouch mucosa possesses altered tight junctions indicating recurrence of inflammatory bowel disease. International Journal of Colorectal Disease 24(10): 1149-1156, 2009

Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease. American Journal of Physiology. Gastrointestinal and Liver Physiology 288(2): G169-G174, 2005

Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management a follow-up study in a private inflammatory bowel disease center (20032017). Journal of Inflammation Research Volume 12: 127-135, 2019